Fluvoxamine
People mainly take Fluvoxamine for anxiety, mood, focus. Based on 5 first-hand reports. Ranked #1126 of 1,974 overall.
14
User score
Mixed20% positive20% mixed0% negative60% unclear
Of reports that state an outcome, 50% are positive.
Clinical research
Research pending
What Fluvoxamine does, according to users
Of the people who reported each effect, the share who said it got better.
betterno changeworse
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
Research data for Fluvoxamine is being compiled.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
No doses stated in the reports so far.
Reported side effects
How often each side effect came up across all reports.
stomach issues ×1sexual dysfunction ×1
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“Some ssris such as fluvoxamine can extend it to 56 hours.”
“In my experience, fluvoxamine is best for cognition like you said, and best in terms of the ratio of side effects to antidepressive/anxiolytic effects.”
“comparing fluvoxamine (an SSRI sigma 1 agonist) to sertraline (an SSRI sigma 1 antagonist) I didn't really notice a difference”
Other options for anxiety
Retatrutide
Peptide · 298 reports
67% report better anxiety
Mostly positiveBResearch: Moderate
Caffeine + L-Theanine
Supplement · 46 reports
100% report better anxiety
Mostly positive
Creatine Monohydrate
Supplement · 139 reports
60% report better anxiety
Mostly positiveAResearch: Strong
Magnesium Malate
Supplement · 103 reports
75% report better anxiety
Mostly positiveDResearch: None
Intermittent Fasting
Lifestyle · 171 reports
80% report better anxiety
Mostly positive
Magnesium Glycinate
Supplement · 910 reports
81% report better anxiety
Mostly positiveCResearch: Limited
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate